181 related articles for article (PubMed ID: 11752445)
1. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus.
Malstrom S; Tili E; Kappes D; Ceci JD; Tsichlis PN
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14967-72. PubMed ID: 11752445
[TBL] [Abstract][Full Text] [Related]
2. Induction of interleukin 2-responsiveness in thymocytes of the transgenic mice carrying lck-transgene.
Moroi Y; Koga Y; Nakamura K; Ohtsu M; Kimura G; Nomoto K
Microbiol Immunol; 1993; 37(5):369-81. PubMed ID: 8102775
[TBL] [Abstract][Full Text] [Related]
3. p27 deficiency cooperates with Bcl-2 but not Bax to promote T-cell lymphoma.
Cheng N; van de Wetering CI; Knudson CM
PLoS One; 2008 Apr; 3(4):e1911. PubMed ID: 18382684
[TBL] [Abstract][Full Text] [Related]
4. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.
Rodriguez-Puebla ML; LaCava M; Miliani De Marval PL; Jorcano JL; Richie ER; Conti CJ
Am J Pathol; 2000 Sep; 157(3):1039-50. PubMed ID: 10980142
[TBL] [Abstract][Full Text] [Related]
6. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D
Oncogene; 2003 Jul; 22(28):4425-33. PubMed ID: 12853979
[TBL] [Abstract][Full Text] [Related]
7. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
8. The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo.
Bryja V; Pacherník J; Faldíková L; Krejcí P; Pogue R; Nevrivá I; Dvorák P; Hampl A
Biochim Biophys Acta; 2004 May; 1691(2-3):105-16. PubMed ID: 15110991
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
11. T-cell development is regulated by the coordinated function of proximal and distal Lck promoters active at different developmental stages.
Chiang YJ; Hodes RJ
Eur J Immunol; 2016 Oct; 46(10):2401-2408. PubMed ID: 27469439
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia.
Robles AI; Larcher F; Whalin RB; Murillas R; Richie E; Gimenez-Conti IB; Jorcano JL; Conti CJ
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7634-8. PubMed ID: 8755527
[TBL] [Abstract][Full Text] [Related]
13. Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity.
Shimizu C; Kawamoto H; Yamashita M; Kimura M; Kondou E; Kaneko Y; Okada S; Tokuhisa T; Yokoyama M; Taniguchi M; Katsura Y; Nakayama T
Int Immunol; 2001 Jan; 13(1):105-17. PubMed ID: 11133839
[TBL] [Abstract][Full Text] [Related]
14. Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulation.
Wang H; Xu Y; Fang Z; Chen S; Balk SP; Yuan X
PLoS One; 2012; 7(7):e41330. PubMed ID: 22844460
[TBL] [Abstract][Full Text] [Related]
15. The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.
van Dyk LF; Hess JL; Katz JD; Jacoby M; Speck SH; Virgin HW IV
J Virol; 1999 Jun; 73(6):5110-22. PubMed ID: 10233974
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D3 and megakaryocyte development: exploration of a transgenic phenotype.
Zimmet JM; Toselli P; Ravid K
Stem Cells; 1998; 16 Suppl 2():97-106. PubMed ID: 11012182
[TBL] [Abstract][Full Text] [Related]
17. Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation.
Rudolph B; Hueber AO; Evan GI
Oncogene; 2001 Mar; 20(10):1164-75. PubMed ID: 11313860
[TBL] [Abstract][Full Text] [Related]
18. Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators.
Chandrasekaran C; Coopersmith CM; Gordon JI
J Biol Chem; 1996 Nov; 271(45):28414-21. PubMed ID: 8910466
[TBL] [Abstract][Full Text] [Related]
19. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids delay age-associated thymic involution through directly affecting the thymocytes.
Pazirandeh A; Jondal M; Okret S
Endocrinology; 2004 May; 145(5):2392-401. PubMed ID: 14736739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
